Talked to Your Peers Lately? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Talked to Your Peers Lately?
Forums, blogs, and more can spark innovation.


Pharmaceutical Technology


Angie Drakulich
We recently added a callout to the end of our peer-reviewed articles, but we're not sure you've seen it. The red icon asks for your input on the published paper: What would you have done differently if it had been your experiment, your process, or your equipment? We, and the authors of the research papers herein, would like your feedback.

We welcome you to email your thoughts to us at
regarding any peer-reviewed papers, or any articles for that matter, that appear in the magazine or on our website and we'll post your comments in a special online section at the end of the appropriate article. Our goal is to encourage more discussion among industry peers to promote the exchange of ideas and ultimately, innovation.

In fact, we just launched a call for nominations for the 2008 Innovations in Pharma Science Awards, which will honor achievements in the pharmaceutical sciences. Check out http://pharmtech.com/Innovations to nominate your company's work in one of five areas: drug delivery, formulation, dosage forms, pharmaceutical analysis, and API synthesis. The winners will be announced in the December issue.

PharmTech also has a daily blog, http://blog.pharmtech.com/, where you can exchange ideas with the editors and experts by commenting on current posts, or adding your own post. What better way is there to increase your industry knowledge and advance your on-the-job skills than to talk to those people doing the same thing you're doing? So join us online and let's get talking.

Angie Drakulich is the managing editor of Pharmaceutical Technology,

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here